Aimovig (Erenumab) Mechanism: Calcitonin Gene-related Peptide Receptor Antagonist Indication: Preventive Treatment of Migraines: Dosing: 70 mg SQ monthly, may increase to 140 mg monthly Aimovig is a biologic that is injected once monthly to prevent migraines in adults! Patients can easily self-administer this subcutaneous injection with the auto-injector device at the abdomen, thigh, or back of arm. Studies reported this drug is fairly tolerable, with primary side effects being injection site reaction (expected) and constipation. Jarred Prudencio, PharmD - https://www.instagram.com/ambcarerx #Aimovig #Erenumab #Migraine #Neurology #Pharmacology #Dosing
